26 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/26/24 13:34
8/23/24
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticBoehm William TD1M.d12415.47084227D
8/23/24 16:30
8/21/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticThrall James HMAD1S-9998.520-134D
8/23/24 16:16
8/21/24
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAncona MargaretUTOSVP,Chie1S-32127.820-1279D
8/21/24 08:26
8/20/24
VNRXVolitionrx LtdDEHealthDiagnIn Vitro & In Vivo DiagnosticInnes Guy ArchibaldNVD1P1010.6700015062,781D
8/20/24 16:38
8/19/24
MYGNMyriad Genetics IncDEHealthDiagnIn Vitro & In Vivo DiagnosticKumar RashmiUTD1S-21028.010-877D
8/16/24 16:30
8/14/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticNiedzwiecki DanielMAOSee Rema1S-24497.540-378D
8/14/24 16:56
8/12/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBer GerardMAD1S-1,49596.480-1621D
8/12/24 17:09
8/8/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticBlanchfield PaulMAOP1S-19396.390-299D
8/7/24 17:01
8/5/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMcKeon Brian PMEOEVP,CFO,1M.d00.0000049D
8/7/24 17:00
8/5/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEO1M.d00.0000082D
8/7/24 10:17
8/6/24
NEOGNeogen CorpMIHealthDiagnIn Vitro & In Vivo DiagnosticTobin James PMID1P5116.86031523D
8/6/24 16:30
8/2/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticHeino Mary AnneMAD1S-1,00195.500-10623D
7/23/24 18:43
7/19/24
QDELQuidelortho CorpHealthDiagnIn Vitro & In Vivo DiagnosticWidder Kenneth JCAD1M.d9327.91031328D
7/17/24 16:30
7/15/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSabens AndreaMAOChief Ac2S.m-294118.490-263D
7/16/24 21:13
7/12/24
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticTelegraph Hill Partners Iv, L.P.CAT1P15,0001.24012,0978326,591I
7/16/24 17:15
7/12/24
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLowell MatthewCAOCFO1P501.2404046128D
7/16/24 17:15
7/12/24
TKNOAlpha Teknova, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticGunstream StephenCADOP,CEO1P1001.2408150243D
7/12/24 16:30
7/10/24
LNTHLantheus Holdings, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticPruden Gary JMAD1S-1,19195.040-1323I
7/11/24 17:15
7/9/24
AWHAspira Women'S Health Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticSchuler Jack WILT2P.d00.0003521,919D
7/3/24 13:15
7/1/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticClark ElianaMAOEVP,Chie1S-922.930071D
6/20/24 17:00
6/17/24
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticVerwiel FrankMAD1S-3825.000-218D
6/18/24 16:05
6/14/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFO2M.d81321.7803728D
6/18/24 16:05
6/14/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMartin Samuel BatesNJOSVP,CFO2S.d-81321.780-3728D
6/18/24 16:04
6/14/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCrowley ElizabethNJOSVP,CPDO2M.d1,35722.620609D
6/18/24 16:04
6/14/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticCrowley ElizabethNJOSVP,CPDO2S.d-1,35722.620-609D
6/13/24 16:05
6/11/24
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticYoung Diane C.NJOSVP,Chie1M.d412.7101570917D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact